IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Andreas Steinmeyer

USPTO Granted Patents = 19

Average Co-Inventor Count = 6.8

ph-index = 7

Forward Citations = 134(Granted Patents)


Company Filing History:

goldMedal18 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 4 
 
Schering Aktiengellschaft
 patents

Years Active: 1994-2007

Loading Chart...
19 patents (USPTO):Explore Patents
1. 7211680 - Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2007-05-01),
2. 7115758 - Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents (2006-10-03),
3. 7071344 - Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments (2006-07-04),
4. 6747046 - Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production and use as pharmaceutical agents (2004-06-08),
5. 6642218 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2003-11-04),
6. 6613920 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents (2003-09-02),
7. 6603031 - Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents (2003-08-05),
8. 6600058 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2003-07-29),
9. 6531459 - Vitamin D derivatives with phosphorus atoms in the side chains (2003-03-11),
10. 6376480 - Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents (2002-04-23),
11. 6372731 - Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments (2002-04-16),
12. 5886233 - Cyclohexanone derivatives, process for their production and intermediate (1999-03-23),
13. 5700791 - Vitamin D derivatives modified in the 20-position and pharmaceutical (1997-12-23),
14. 5663157 - 22-en-25-oxa derivatives in the vitamin D series, process for their (1997-09-02),
15. 5585368 - 20-position modified pharmaceutically active vitamin D series compounds (1996-12-17),

Title: Innovations in Vitamin D Derivatives by Andreas Steinmeyer

Introduction

Andreas Steinmeyer is a prominent inventor based in Berlin, Germany, known for his significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 19 patents, he specializes in the development of vitamin D derivatives, which play a crucial role in therapeutics for various diseases.

Latest Patents

Steinmeyer’s latest innovations include two advanced patents involving vitamin D derivatives with standout functionalities. The first patent outlines vitamin D derivatives with carbo- or heterocyclic substituents at C-25 along with a comprehensive process for their production. These compounds are particularly valuable for treating hyperproliferative skin diseases, tumor conditions, autoimmune diseases, and a range of other health issues, including diabetes and osteoporosis.

The second patent continues in a similar vein, detailing vitamin D derivatives with cyclic substructures in their side chains. This invention also includes processes and intermediate products for the efficient production of pharmaceutical agents, allowing for further advancements in the therapeutic landscape.

Career Highlights

Andreas Steinmeyer has a distinguished career that includes pivotal roles at Schering Aktiengesellschaft, a company renowned for its research in biopharmaceuticals and innovative healthcare solutions. His work has significantly advanced the understanding and applications of vitamin D in medicine.

Collaborations

Steinmeyer has collaborated with notable colleagues such as Martin Haberey and Katica Schwarz. Together, their combined expertise has led to groundbreaking developments in the field, pushing the boundaries of how vitamin D derivatives can be utilized in treating complex medical conditions.

Conclusion

Andreas Steinmeyer continues to be a leading figure in the pharmaceutical industry, with a focus on vitamin D derivatives and their potential to transform therapeutic options available for various diseases. His innovative spirit and dedication to research showcase the vital link between invention and healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…